Warfarin versus aspirin for stroke prevention (BAFTA)

Lancet

Volumn 370, Issue 9599, 2007, Pages 1606-

  Diug, Basia ^a   Lowthian, Judy ^a   Evans, Sue ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

BLEEDING; ELDERLY CARE; HUMAN; LETTER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; STROKE; AGED; NOTE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; HUMANS; RISK FACTORS; STROKE; WARFARIN;

EID: 35748948036     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61678-X     Document Type: Letter

References (5)

1. Mant J., Hobbs F., Fletcher K., et al., on behalf of the BAFTA investigators, the Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of Aged Study, BAFTA): a randomised controlled trial. Lancet 370 (2007) 493-503
2. Mant J., Richards S., Hobbs F., et al. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population. BMC Cardiovasc Disord 3 (2003) 9
3. Hutchison L., Jones S., West D., and Wei J. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Am J Geriatric Pharmacother 4 (2006) 144-153
4. Fang M., Machtinger E., Wang F., and Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med 21 (2006) 841-846
5. Oden A., and Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 325 (2002) 1073-1075